Therefore, STK35 overexpression was capable of completely offsetting the observed anti-CRC effects exhibited by NEDD4L overexpression, and it simultaneously recued the cellular p-AKT back to an even higher level. This evidence concerns the gene NEDD4L and colorectal carcinoma.